Valion Bio Inc.

Last updated September 27, 2026

Organization details

Legal name
Valion Bio Inc.
Former names
Tivic Health Systems, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Antonio
Headquarters state / province
Texas
Headquarters country
United States
Fiscal year end
December
Ticker symbol
VBIO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001787740
EIN
81-4016391

Board of directors

Chief executives

Jennifer Ernst · Chief Executive Officer
Dates unknown
Michael K. Handley · Chief Executive Officer
Dates unknown
Dean Zikria · Interim CEO Interim
Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 3 other boards. 2 are in the same sector.

Network of Valion Bio Inc.'s board connections Outset Medical Inc. Outset Medical Inc. Precipio Inc. Precipio Inc. ResMed Inc. ResMed Inc. Christina Rizopoulos Valauri Christina Rizopoulos... Karen Drexler Karen Drexler Valion Bio Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$28,450
2 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 18, 2026 Wolf Lisa G Officer (COO & CFO) Option exercise +4 — —
Sep 18, 2026 Wolf Lisa G Officer (COO & CFO) Shares withheld for tax −2 $2.12 $4
Jun 18, 2026 Wolf Lisa G Officer (Chief Financial Officer) Option exercise +92 — —
May 18, 2026 Michael K. Handley Director, Officer (Chief Executive Officer) Option exercise +2,206 — —
Apr 15, 2026 Sheryle Bolton Director Open-market purchase +10,000 $1.04 $10,400
Apr 1, 2026 Christina Rizopoulos Valauri Director Open-market purchase +19,000 $0.95 $18,050
Mar 18, 2026 Wolf Lisa G Officer (Chief Financial Officer) Option exercise +92 — —
Feb 18, 2026 Handley Michael K Officer (Chief Operating Officer) Option exercise +8,824 — —
Dec 18, 2025 Wolf Lisa G Officer (Chief Financial Officer) Option exercise +736 — —
Dec 18, 2025 Jennifer Ernst Director, Officer (Chief Executive Officer) Option exercise +14,706 — —
Dec 18, 2025 Wolf Lisa G Officer (Chief Financial Officer) Shares withheld for tax −302 $1.87 $565
Dec 18, 2025 Jennifer Ernst Director, Officer (Chief Executive Officer) Shares withheld for tax −5,262 $1.87 $9,840
Sep 22, 2025 Jennifer Ernst Director, Officer (Chief Executive Officer) Grant or award +22,541 — —
Mar 12, 2024 Bambach Kimberly Ann Officer (Interim CFO) Grant or award +7,500 — —
May 16, 2022 Karen Drexler Director Other −15,111 — —

Organizations in the same sector, closest in location and size first.

Questions about Valion Bio Inc.

Who is the CEO of Valion Bio Inc.?

Jennifer Ernst is Valion Bio Inc.'s Chief Executive Officer.

How many directors are on Valion Bio Inc.'s board?

Valion Bio Inc.'s board has 8 directors: Christina Rizopoulos Valauri, Dean Zikria, Jared David Malbin, Jennifer Ernst, Karen Drexler, Michael K. Handley, Sheryle Bolton and Thomas Jensen.

Are Valion Bio Inc. insiders buying or selling shares?

Over the last 12 months, Valion Bio Inc. insiders bought $28,450 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="valion-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.